HONG KONG, Nov. 16, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise in China, today announces that it has formed a strategic collaboration with GE Healthcare. Pursuant to the collaboration, GE Healthcare will provide an integrated and automated digital system and solutions to the Group's umbilical cord blood cryopreservation processes, aiming to provide efficient storage services to customers at large.
Medical research in the past three decades have shown that umbilical cord blood contains rich hematopoietic stem cells. These stem cells could facilitate the reconstruction of hematopoietic and immune systems, and could also be applied to hematopoietic stem cell transplantation as well as the treatment of blood system, immune system and inherited metabolic diseases. Therefore, umbilical cord blood has become an important source of hematopoietic stem cells and is widely used clinically. Cord blood bank operation usually include cord blood collection and processing, laboratory testing, stem cell cryopreservation and storage. All these processes demanded high standard protocols. Through its partnership with GE Healthcare, the Group will utilise a fully automated cell processing system and associated disposable kit to meet the stringent requirements for extensive cord blood processing in an efficient and safe manner.
About Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801)
Golden Meditech (www.goldenmeditech.com) is a leading integrated-healthcare enterprise in China. It is a first-mover in China, having established its dominant positions in several markets including the medical devices market, the cord blood storage market and the hospital management market in the healthcare industry, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, Golden Meditech will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.
About GE Healthcare
Harnessing data and analytics across hardware, software and biotech, GE Healthcare is the $18 billion healthcare business of GE (NYSE: GE). As a leading provider of medical imaging equipment, with a track record of more than 100 years in the industry and more than 50,000 employees across 100 countries, we transform healthcare by delivering better outcomes for providers and patients.
SOURCE Golden Meditech Holdings Limited